Guiyin Sun
Chongqing, 402260, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
The Emerging Role of ADAM 12 Regulates Epithelial-mesenchymal Transition by Activating the Wnt/β-catenin Signaling Pathway in Colorectal Cancer.
Journal: Recent patents on anti-cancer drug discovery
Published: February 21, 2024
Nrf1 is not a direct target gene of SREBP1, albeit both are integrated into the rapamycin-responsive regulatory network in human hepatoma cells.
Journal: PloS one
Published: February 14, 2023
Overcoming tumor microenvironment obstacles: Current approaches for boosting nanodrug delivery.
Journal: Acta biomaterialia
Published: February 10, 2023
ECM1 regulates the resistance of colorectal cancer to 5-FU treatment by modulating apoptotic cell death and epithelial-mesenchymal transition induction.
Journal: Frontiers in pharmacology
Published: July 28, 2022
Distinct Roles of Nrf1 and Nrf2 in Monitoring the Reductive Stress Response to Dithiothreitol (DTT).
Distinct Roles of Nrf1 and Nrf2 in Monitoring the Reductive Stress Response to Dithiothreitol (DTT).
Journal: Antioxidants (Basel, Switzerland)
Published: July 09, 2022
The Role of MicroRNA in the Regulation of Tumor Epithelial-Mesenchymal Transition.
Journal: Cells
Published: May 04, 2022
Extracellular Matrix Protein 1 Regulates Colorectal Cancer Cell Proliferative, Migratory, Invasive and Epithelial-Mesenchymal Transition Activities Through the PI3K/AKT/GSK3β/Snail Signaling Axis.
Journal: Frontiers in oncology
Published: March 03, 2022
Poricoic acid A (PAA) inhibits T-cell acute lymphoblastic leukemia through inducing autophagic cell death and ferroptosis.
Journal: Biochemical and biophysical research communications
Published: December 28, 2021
Efficacy and Safety of Iodine-125 Brachytherapy in the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
Journal: OncoTargets and therapy
Published: June 27, 2020
ZEB1 promotes colorectal cancer cell invasion and disease progression by enhanced LOXL2 transcription.
Journal: International journal of clinical and experimental pathology
Published: May 05, 2020
DDX49 is a novel biomarker and therapeutic target for lung cancer metastases.
Journal: Journal of cellular and molecular medicine
Published: May 20, 2019
Last Updated: 09/26/2026